These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21856493)

  • 1. Regarding early initiation of dialysis.
    Senekjian HO
    Am J Kidney Dis; 2011 Sep; 58(3):492; author reply 492. PubMed ID: 21856493
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of end stage renal disease (ESRD) -- the debate continues.
    Feng PH
    Singapore Med J; 1982 Feb; 23(1):1-2. PubMed ID: 7112134
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of renal failure in the light of increasingly limited resources.
    Wing AJ
    Contrib Nephrol; 1985; 44():260-74. PubMed ID: 3987290
    [No Abstract]   [Full Text] [Related]  

  • 4. Early dialysis of no benefit to the patient or the health care system.
    Manns BJ; Quinn RR
    Am J Kidney Dis; 2011 May; 57(5):649-50. PubMed ID: 21496724
    [No Abstract]   [Full Text] [Related]  

  • 5. Resource use and patient care associated with chronic kidney disease in a managed care setting.
    Robbins JD; Kim JJ; Zdon G; Chan WW; Jones J
    J Manag Care Pharm; 2003; 9(3):238-47. PubMed ID: 14613467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predialysis nephrology care and costs in elderly patients initiating dialysis.
    Stroupe KT; Fischer MJ; Kaufman JS; O'Hare AM; Sohn MW; Browning MM; Huo Z; Hynes DM
    Med Care; 2011 Mar; 49(3):248-56. PubMed ID: 21224743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policies and health care financing issues for dialysis in Latin America: extracts from the roundtable discussion on the economics of dialysis and chronic kidney disease.
    Pecoits-Filho R; Campos C; Cerdas-Calderon M; Fortes P; Jarpa C; Just P; Luconi P; Lugon JR; Pacheco A; Paniagua R; Rodriguez K; Sanabria M; Sciaraffia V; Velasco C; De Arteaga J
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S222-6. PubMed ID: 19270223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The organization and financing of dialysis and kidney transplantation services in New Zealand.
    Ashton T; Marshall MR
    Int J Health Care Finance Econ; 2007 Dec; 7(4):233-52. PubMed ID: 17638073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The financing and organization of medical care for patients with end-stage renal disease in Sweden.
    Wikström B; Fored M; Eichleay MA; Jacobson SH
    Int J Health Care Finance Econ; 2007 Dec; 7(4):269-81. PubMed ID: 17657602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The organization and financing of end-stage renal disease in Spain.
    Luño J
    Int J Health Care Finance Econ; 2007 Dec; 7(4):253-67. PubMed ID: 17602295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Study of Health Care Organization and Financing of renal services in England and Wales.
    Nicholson T; Roderick P
    Int J Health Care Finance Econ; 2007 Dec; 7(4):283-99. PubMed ID: 17653861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kidney dialysis and transplantation].
    Makó J
    Orv Hetil; 2000 Dec; 141(50):2749. PubMed ID: 11189682
    [No Abstract]   [Full Text] [Related]  

  • 13. Socioeconomic problems related with chronic renal failure in Sweden.
    Bergström J
    Contrib Nephrol; 1989; 71():155-7. PubMed ID: 2805693
    [No Abstract]   [Full Text] [Related]  

  • 14. The organization and financing of kidney dialysis and transplant care in the United States of America.
    Hirth RA
    Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESRD modality selection into the 21st century: the importance of non medical factors.
    Nissenson AR; Prichard SS; Cheng IK; Gokal R; Kubota M; Maiorca R; Riella MC; Rottembourg J; Stewart JH
    ASAIO J; 1997; 43(3):143-50. PubMed ID: 9152482
    [No Abstract]   [Full Text] [Related]  

  • 16. Establishing and controlling chronic renal failure treatment costs. A pressing need.
    Martín Hernández R
    Nefrologia; 2011; 31(3):256-9. PubMed ID: 21629334
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis.
    Rocha MJ; Ferreira S; Martins LS; Almeida M; Dias L; Pedroso S; Henriques AC; Almeida R; Cabrita A
    Clin Transplant; 2012; 26(4):529-31. PubMed ID: 22211715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESRD demonstration aligns incentives.
    Neumann ME
    Nephrol News Issues; 2011 Feb; 25(2):8. PubMed ID: 21466017
    [No Abstract]   [Full Text] [Related]  

  • 19. Examination of resource use and clinical interventions associated with chronic kidney disease in a managed care population.
    London R; Solis A; Goldberg GA; Wade S; Chan WW
    J Manag Care Pharm; 2003; 9(3):248-55. PubMed ID: 14613468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End stage renal disease--the end of the road.
    Rao M
    Natl Med J India; 1992; 5(5):241-3. PubMed ID: 1302587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.